Publications by authors named "Unmesh Gopalakrishnan"

Claim this Profile
L
Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis.
Hisashi Yamanaka, Yoshiya Tanaka, Toshihiko Hibino, Gopalakrishnan Unmesh, Chirag Shah

Int J Rheum Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial.
Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson

Breast· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson

Breast Cancer Res Treat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis